SCHEMBL5031013

SCHEMBL5031013

CCCC[Si](OC1CCCCC1)(OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 3/20 0.41
CYP1A2 P05177 1/20 0.40
EPHX1 P07099 9/20 0.36
CNR2 P34972 5/20 0.35
CNR1 P21554 4/20 0.35
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5031089 0.94 NAAA (0.43) NAAACYP1A2EPHX1CNR2CNR1
SCHEMBL5551412 0.87 EPHX1 (0.38) NAAACYP1A2EPHX1
SCHEMBL8978994 0.83 NAAA (0.41) NAAACYP1A2EPHX1CNR2CNR1
Methylamine SCHEMBL2251740 0.83 EPHX1 (0.36) NAAACYP1A2EPHX1
SCHEMBL1518607 0.79 SIGMAR1 (0.38)
SCHEMBL10597822 0.79 NAAA (0.38) NAAACYP1A2EPHX1CNR2CNR1
SCHEMBL11420334 0.79 HDAC4 (0.30)
SCHEMBL11424995 0.79 HDAC4 (0.30)
SCHEMBL31294342 0.79 SIGMAR1 (0.38)
SCHEMBL1518838 0.79 SIGMAR1 (0.43) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed